Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the move on Wednesday morning.

At the time of writing, the ASX radiopharmaceuticals stock is down 7.5% to $14.28.

As a comparison, the ASX 200 index is trading 0.25% higher in morning trade today.

Why are Telix shares falling today?

The company’s shares are under pressure following the announcement of a large convertible bond offering due in 2031.

According to the release, Telix has raised US$600 million from the convertible notes offering.

These notes can be converted into ordinary Telix shares at a future date, which introduces the potential for dilution if conversion occurs.

Management noted that the proceeds will primarily be used to refinance its existing convertible bonds due 2029, with any excess funds directed toward general corporate purposes.

The bonds are expected to carry a relatively low coupon of between 1.50% and 1.75% and will be issued with a conversion price of US$13.85 (~A$19.55), which is a premium of approximately 37.5% to the current share price.

While the company described the transaction as cost-effective financing, the combination of potential dilution and associated hedging activity appears to be weighing on sentiment.

Telix’s managing director and group CEO, Dr. Christian Behrenbruch, said:

The refinance of the existing Convertible Bonds represents our proactive approach to capital management. The new Convertible Bonds will continue to provide the business with cost effective financing.

The successful completion of the convertible bonds refinance is in line with our capital management strategy and provides financial flexibility for Telix. We are pleased with the support we have received from both existing and new investors as part of the concurrent repurchase and new issue of convertible bonds.

Investor presentation

Alongside the announcement, Telix also released an updated investor presentation, which largely reiterated previously disclosed performance and outlook details.

The presentation highlights that the company generated group revenue of US$230 million in the first quarter of 2026, representing an 11% increase on the previous quarter and a 23.7% jump on the prior corresponding period.

Looking ahead, Telix continues to guide to FY 2026 revenue in the range of US$950 million to US$970 million. This will be supported by growth in its Precision Medicine business and contributions from its radiopharmacy operations.

Its research and development guidance range remains US$200 million to US$240 million.

And this appears to be money well spent. The company pointed to progress across its pipeline, including multiple late-stage clinical programs and upcoming regulatory milestones.

It also spoke about its significant market opportunity in the US market. Management estimates that it has a US$32 billion addressable market across its Precision Medicine and Therapeutics pipeline.

The post Why are Telix shares sinking 7.5% today? appeared first on The Motley Fool Australia.

More reading

• Telix Pharmaceuticals upsizes convertible bonds to US$600 million
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances
• 5 things to watch on the ASX 200 on Wednesday
• Why Monash IVF, Pro Medicus, Telix, and Woodside shares are storming higher today
• Telix share price leaping higher today on $3 billion US news

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Boss Energy Ltd (ASX: BOE) shares are sinking on Wednesday morning.

At the time of writing, the ASX 300 uranium stock is down almost 14% to $1.49.

Why are Boss Energy shares crashing?

The company’s shares are under pressure following the release of a production update that included a downgrade to its FY 2026 guidance.

According to the release, Boss Energy has reduced its FY 2026 production guidance for the Honeymoon operation to between 1.40 million and 1.45 million pounds of U3O8. This is down from previous guidance of 1.6 million pounds.

Management advised that the downgrade is largely due to ongoing disruptions caused by heavy rainfall.

Boss Energy had previously flagged that rain impacted third quarter production by restricting site access and limiting the delivery of key materials. However, further unexpected rainfall during March extended these disruptions beyond initial expectations.

As a result, production for the third quarter came in at just 203,000 pounds of U3O8. This is below the previously guided range of 240,000 to 270,000 pounds.

Looking ahead, fourth quarter production is now expected to be between 356,000 and 406,000 pounds, which is also below earlier expectations.

Infrastructure delays add to pressure

In addition to weather-related issues, Boss Energy experienced delays in commissioning key infrastructure.

This includes components required to support the ramp-up in production, such as NIMCIX columns and associated pumping systems, as well as the completion of wellfield infrastructure.

These delays, combined with restricted site access, have contributed to the lower production outlook.

Costs remain unchanged

One positive is that despite the downgrade to production, the company has maintained its cost guidance.

Boss Energy expects FY 2026 C1 costs to remain in the range of $36 to $40 per pound, and all-in sustaining costs between $60 and $64 per pound.

However, management noted that costs are now expected to come in toward the upper end of these ranges due to factors such as higher fuel and transport expenses.

Commenting on the update, Boss Energy’s managing director, Matthew Dusci, said:

We recognise this downgrade is disappointing, particularly after maintaining guidance as recently as March. At that time, our expectation was that site access and reagent deliveries would normalise during the month. Subsequent unexpected rainfall, combined with the degraded baseline condition of access roads, extended disruption materially beyond that assumption. This has impacted both production and the timing of commissioning critical infrastructure during ramp-up.

While weather-related access constraints were a key factor, delays to certain infrastructure, mainly associated with the commissioning of the additional PLS and BLS pumps, have also contributed to the revised production outcome and guidance for FY26.

Despite this setback, Dusci remains positive on its outlook. He concludes:

These events have impacted performance in the short-term, however we anticipate rebounding to a normalised FY26 production run rate over the course of Q4 FY26. Our immediate focus is restoring targeted lixiviant chemistry, completing commissioning of additional capacity, and exiting FY26 with the operation better positioned for FY27.

The post Why are Boss Energy shares crashing 14% today? appeared first on The Motley Fool Australia.

More reading

• Why Boss Energy, Macquarie, Nova Minerals, and WiseTech shares are storming higher today
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• Bell Potter says this ASX penny stock could rocket 90%
• These are the 10 most shorted ASX shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Yancoal Australia Ltd (ASX: YAL) shares are on the move on Wednesday morning.

At the time of writing, the ASX 200 coal stock is up 1.5% to $7.32 after returning from a short trading halt.

Why is this ASX 200 coal stock rising today?

The catalyst for the move has been the announcement of a major acquisition.

According to the release, Yancoal has entered into binding agreements to acquire an 80% interest in the Kestrel coal mine in Queensland’s Bowen Basin.

The transaction will be completed through the acquisition of Kestrel Coal Group, which holds the interest in the mine.

The total consideration for the deal is up to US$2.4 billion. This includes an upfront payment of US$1.85 billion, as well as contingent payments of up to US$550 million that are linked to future coal prices.

Management describes Kestrel as a high-quality, long-life asset, producing premium metallurgical coal that is used in steelmaking. It is the largest producing underground coal mine in Australia, which highlights the scale of the acquisition.

Strategic benefits

The ASX 200 coal stock believes the acquisition is a strong strategic fit for its existing portfolio.

The addition of Kestrel is expected to increase the company’s exposure to metallurgical coal, lifting its share of production to approximately 22% on a pro forma basis.

This is significant given that metallurgical coal typically commands higher margins and is linked to global steel demand.

The asset is also located near Yancoal’s existing operations in the Bowen Basin, which may provide operational and logistical benefits over time.

Funding

Yancoal plans to fund the acquisition through a combination of existing cash, debt facilities, and future cash flows from the enlarged business.

The transaction remains subject to a number of regulatory approvals and conditions.

Completion is currently targeted for the second half of calendar 2026, assuming all approvals are received.

Commenting on the acquisition, the ASX 200 coal stock’s CEO, Sharif Burra, said:

The proposed acquisition of 80% of the Kestrel Coal Mine represents a strong strategic fit for Yancoal and adds another high-quality, long-life mine to our portfolio. Kestrel delivers increased scale and diversification to Yancoal’s portfolio and is expected to contribute premium metallurgical coal into our product mix.

The acquisition positions us to deliver greater value to our shareholders and consolidates Yancoal’s position as a leading Australian coal miner. We look forward to working closely with Mitsui, the joint venture partner and owner of 20% of Kestrel, in the future as co-owners of Kestrel to continue to add value to the mine, local communities and stakeholders.

The post ASX 200 coal stock higher on US$2.4 billion deal appeared first on The Motley Fool Australia.

More reading

• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• 7 ASX 200 shares just upgraded to strong buy ratings
• ASX 200 energy shares whipsaw amid fragile ceasefire
• These were the best-performing ASX 200 shares in March
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Many ASX stocks fell during the month of March as global conflict weighed heavily on sentiment. 

This has prompted plenty of coverage from the team at The Motley Fool about where investors should be scooping up value shares.

In addition to plenty of shares that may have been oversold during March, there are also ASX stocks that ignored broader market negativity and powered ahead. 

Let’s look at three that have flown higher in 2026 despite broader volatility.

4DMedical Ltd (ASX: 4DX)

For those who missed it, 4DX Medical was one of the best ASX stocks to own in 2025. 

It is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.

The company’s non-invasive lung imaging technology emanates from research work undertaken at Monash University. 

It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.

In the last 12 months, this ASX stock has risen 2,000%. 

Yes, you read that right. 

While this rapid pace has slowed, it has still enjoyed a 39% rise year to date. 

For context, the S&P/ASX 200 Index (ASX: XJO) is up just 2.8% in the same period. 

So, where to now for this ASX stock?

Many holders would be considering profit-taking, while those on the outside looking in might have missed the boat. 

The Motley Fool’s Samantha Menzies dove into this question recently, pointing out the gamble that some investors might be taking. 

It’s possible this runaway train is now rising more on hype and hope rather than concrete earnings. 

Analysts forecasts via TradingView indicate it is now above fair value by approximately 34%. 

PLS Group Ltd (ASX: PLS)

PLS is an Australian lithium-tantalum producer positioning itself at the forefront of the rapidly growing global lithium industry.

While it hasn’t been all smooth sailing, PLS shares are up 25% year to date and 283% in the last 12 months. 

Global lithium prices have been driving this growth, along with its dominant market position here in Australia. 

These drivers could continue to benefit this ASX 200 stock in the long term. 

However, 17 analyst forecasts via TradingView indicate that right now, it is trading close to fair value. 

Resolute Mining Ltd (ASX: RSG)

Resolute Mining is an Australia-based gold producer.

Like most gold stocks, it rallied throughout 2025. 

But while many other companies in the sector have fallen this year, Resolute Mining shares have continued to climb a further 17% in 2026. 

Unlike the previous ASX stocks mentioned, experts think Resolute Mining shares can continue to climb. 

7 analysts via TradingView have an average one-year price target of $2.13. 

This suggests a potential upside of 47% from current levels. 

The post Will these top-performing ASX stocks keep charging higher? appeared first on The Motley Fool Australia.

More reading

• This ASX lithium giant just hit a record high again. Here’s why investors keep chasing it
• Up 106% in six months, here are the latest growth forecasts for the PLS Group share price
• PLS shares jump 320% in 12 months: Buy, sell or hold?
• 2 ASX 200 mining shares this fund manager is backing for long-term growth
• Are investors taking a big gamble chasing 4DX shares higher and higher?

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The decade before retirement can make or break your long-term financial future. It’s the period when your portfolio is often at its largest, your super balance has the most to lose from a market correction, and every investment decision carries more weight.

That’s exactly why I believe Australian investors should focus on a strategy that blends growth, resilience, and rising income.

For retirees who own their home, the latest ASFA Retirement Standard suggests a couple needs around $77,000 a year for a comfortable lifestyle, while singles need roughly $55,000.

That makes the final 10 years before retirement the ideal time to shape a portfolio designed to support that level of spending.

Local and global reach through ETFs

My preferred approach starts with broad ASX and global share ETFs as the portfolio’s growth engine. A core holding in the Vanguard Australian Shares ETF (ASX: VAS) gives investors exposure to many of the market’s best dividend-paying companies.

Adding an international ETF such as BetaShares Global Shares ETF (ASX: BGBL) helps diversify beyond the banks and miners that dominate the local market.

Together, these ETFs can still deliver the capital growth needed to keep pace with inflation over what could be a 25-year retirement.

Increase income, limit risk

But this is also the decade when income starts to matter more. That’s why I like gradually introducing a high-yield ETF such as SPDR MSCI Australia Select High Dividend Yield Fund (ASX: SYI). The higher dividend stream, supported by franking credits, can help lift the portfolio’s cash generation without relying entirely on selling units.

At the same time, reducing risk becomes critical. A major market sell-off just before retirement can permanently damage a drawdown plan, which is why I would steadily increase exposure to bond ETFs such as the Vanguard Australian Fixed Interest ETF (ASX: VAF).

Bonds may not deliver eye-catching returns, but they can provide stability and act as a valuable shock absorber when share markets turn volatile.

Blue chips for growth

I’d also reserve a smaller slice of the portfolio for a handful of elite ASX blue-chip shares. Names such as Commonwealth Bank of Australia (ASX: CBA), Wesfarmers Ltd (ASX: WES), and CSL Ltd (ASX: CSL) can add a blend of dependable dividends and long-term earnings growth. These businesses have the scale and quality to remain core holdings well into retirement.

The real secret, though, is the glide path. Ten years out, I’d still lean heavily into shares. Five years from retirement, I’d be lifting bond and cash exposure. By retirement day, I’d want at least two years of living expenses sitting in cash or term deposits, ready to fund spending needs without touching shares in a downturn.

That combination of ASX ETFs, quality blue chips, bonds, and a cash buffer creates exactly what pre-retirees need most: a portfolio built not just to grow wealth, but to defend it when it matters most.

The post 10 years to retirement? Here’s how to build a solid income appeared first on The Motley Fool Australia.

More reading

• How I would build the ultimate beginner portfolio with $10,000
• What on earth’s going on with CSL shares?
• CBA shares jump another 9.5% in April: Buy, sell or hold?
• Just starting out? These 5 ASX shares could be the perfect first buy
• How ASX ETF investors repositioned as the Iran war shook markets

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Wesfarmers. The Motley Fool Australia has recommended CSL and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Virgin Australia Holdings Ltd (ASX: VGN) share price is in focus after the airline confirmed its FY26 financial guidance remains unchanged, with underlying EBIT and EBIT margin expected to improve in 2HFY26 despite a surge in fuel prices.

What did Virgin Australia report?

• FY26 financial guidance unchanged; 2HFY26 underlying EBIT and EBIT margin both expected to be higher than 2HFY25
• Group leverage at 0.8x net debt/underlying EBITDA, below its 1–2x target range
• Liquidity position of $1.5 billion at 31 March 2026
• Fuel costs of $554.7 million for 1HFY26, representing 21% of total operating expenses
• 2HFY26 RASK (revenue per available seat kilometre) growth expected at approximately 5%, up from prior 3–4% guidance

What else do investors need to know?

Virgin Australia has responded to fuel price volatility by adjusting fares and domestic capacity, with 2HFY26 capacity now expected to rise 1% but fall 1% in the fourth quarter. Strong fuel hedging means the group is protected from most rises, with 92% of Brent crude and 71% of refining margin exposure hedged for the remainder of FY26.

Although jet fuel prices have more than doubled since late February, Virgin Australia expects the increase in fuel costs for 2HFY26 to be about $30–40 million above earlier forecasts. The airline reports continued supply assurance from its fuel suppliers for operations into May.

What’s next for Virgin Australia?

Virgin Australia says its outlook for FY26 remains solid, assuming no major changes to demand, jet fuel prices, or fuel supply in the near term. For early FY27, the company has continued strong hedging (93% of Brent crude but only 15% of refining margin), and reviews are underway to adjust capacity if volatility persists. The business remains confident in its flexible cost and hedging strategies to navigate uncertainty.

Virgin Australia share price snapshot

Over the past 12 months, Virgin Australia shares have declined 27%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Virgin Australia’s FY26 update: Hedging cushions rising fuel costs appeared first on The Motley Fool Australia.

More reading

• National Storage REIT: Scheme meetings confirm buyout pathway
• Evolution Mining delivers record cash flow and moves to net cash
• Telix Pharmaceuticals upsizes convertible bonds to US$600 million
• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The National Storage REIT (ASX: NSR) share price is in focus as investors digest news of the proposed $2.80-per-security cash offer from a Brookfield and GIC consortium, valuing the group at over $4 billion. Security holders who held NSR securities at the record date also received a permitted distribution, taking the total cash value per security to $2.86.

What did National Storage REIT report?

• The consortium of Brookfield and GIC has proposed to acquire 100% of National Storage REIT for $2.80 cash per security.
• Eligible securityholders who held units as at 31 December 2025 have received a 6 cent permitted distribution, giving a total of $2.86 per security.
• Kroll, the Independent Expert, valued NSR securities at $2.72–$2.86 and found the deal fair and reasonable.
• National Storage’s enterprise value sits at around $6.7 billion, with FY26 1H underlying earnings up over 8% and REVPAM up 5.3%.
• The business now operates 300 centres, serving more than 100,000 customers across Australia and New Zealand.

What else do investors need to know?

The proposed transaction is structured as a scheme of arrangement and trust scheme, requiring both security holder and court approval. Meetings took place on 15 April 2026 to vote on several resolutions relating to the buyout and company structure changes.

Directors unanimously recommended the transaction and confirmed they would vote their own holdings in favour, with no superior offer having emerged. Major regulatory approvals, such as from FIRB and the New Zealand Overseas Investment Office, have already been secured.

If approved, remaining steps include court approval expected on 21 April 2026, with implementation set for 8 May 2026. Trading in NSR securities will be suspended following effectiveness, and eligible holders as of the record date will receive their cash consideration promptly.

What’s next for National Storage REIT?

The focus now turns to the court’s decision and the final implementation of the acquisition. If all conditions are met, the transaction is expected to deliver a certain, all-cash outcome for investors — within the Independent Expert’s fair value range.

After a period of strong growth as a listed entity, National Storage REIT is set to transition to private ownership. The board expressed gratitude for stakeholder support and optimism for the company’s ongoing role in self-storage innovation under new ownership.

National Storage REIT share price snapshot

Over the past 12 months, National Storage REIT shares have risen 28%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post National Storage REIT: Scheme meetings confirm buyout pathway appeared first on The Motley Fool Australia.

More reading

• Virgin Australia’s FY26 update: Hedging cushions rising fuel costs
• Evolution Mining delivers record cash flow and moves to net cash
• Telix Pharmaceuticals upsizes convertible bonds to US$600 million
• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Since late March, it seems sentiment in equities has recovered quickly. 

This has been consistent across both ASX and global shares. 

After falling 9% over the first three weeks of March, the S&P/ASX 200 Index (ASX: XJO) has since rebounded 7%.

Geopolitical shocks and volatility are inevitable during the life of an investor. 

However, this recent recovery shows just how quickly markets can recover. 

Despite the recovery, there are still ASX 200 stocks that haven’t enjoyed the same rebound. 

Here are three still sitting well below fair value according to brokers. 

Life360 Inc (ASX: 360)

For a long time, Life360 shares enjoyed a strong and almost uninterrupted rise.

The company’s core product is a private family and friends social networking app that allows users to communicate and share their locations. 

After peaking at more than $55 per share in October last year, they have since fallen significantly. 

At the time of writing, they are down 66% since hitting all-time highs and closed yesterday at $18.58. 

However, this could now be an opportunity for investors to buy low on a quality company, as the business continues to grow its user base and monetisation.

The team at Bell Potter agrees.

The broker has a buy rating on this ASX 200 stock, with a price target of $35.50. 

From yesterday’s closing price, this indicates an upside of more than 90%. 

Guzman y Gomez Ltd (ASX: GYG)

It has been a turbulent start to life as an ASX 200 stock for GYG. 

After first listing on the ASX in June last year, it quickly rode positive momentum to more than $43 per share. 

However, since then, the fast casual Mexican-inspired food chain has seen its share price fall more than 50%. 

It closed yesterday at $19.96 per share. 

However, the company recently posted a positive third-quarter update, prompting a positive response from Morgans.

The broker has retained their buy rating on this ASX 200 stock with an improved price target of $26.70.

From yesterday’s closing price, this indicates a potential upside of almost 34%. 

Harvey Norman Holdings Ltd (ASX: HVN)

Harvey Norman shares have suffered along with many consumer discretionary shares this year. 

The Australian-based retailer has seen its share price dip 34% year to date. 

It now appears to be another ASX 200 stock trading below fair value. 

Bell Potter currently has a buy rating with a price target of $6.70.

From yesterday’s closing share price of $4.61, that indicates an upside potential of just over 45%. 

The post 3 discounted ASX 200 shares to buy before they rebound  appeared first on The Motley Fool Australia.

More reading

• How to invest $300 a month in Australian shares to target a $50,000 annual second income
• 3 high-quality ASX shares to buy while they are cheap
• Consumer discretionary shares to target for a long-term rebound
• Have these top ASX shares been sold off too far?
• These 3 ASX 200 stocks hit a 52-week low: Buy, sell or hold?

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Harvey Norman and Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Evolution Mining Ltd (ASX: EVN) share price is in focus as the company moved to a net cash position in the March 2026 quarter, generating $406 million in group cash flow and maintaining strong operational delivery. Record quarterly net mine cash flows at Mungari and Red Lake were standout highlights.

What did Evolution Mining report?

• Group net cash position of $42 million as at 31 March 2026, up from net debt in prior quarters
• March quarter group cash flow of $406 million ($2,482/oz)
• Record quarterly net mine cash flows: Mungari ($175 million) and Red Lake ($104 million)
• March quarter gold production of 170,000 ounces and copper production of 11,000 tonnes
• All-in Sustaining Cost (AISC) of $2,220/oz for the quarter
• Total cash balance of $1,371 million, up $404 million; no debt repayments until FY29

What else do investors need to know?

The company remains on track to deliver full year FY26 gold production at a lower cost than originally guided, even as group copper production is expected around the low end of guidance due to recent weather events at Ernest Henry. Investments in organic growth projects at Northparkes and Ernest Henry are proceeding on time and budget, positioning Evolution for future expansion.

During the period, Evolution announced exciting high-grade drilling results at Mungari and Cowal, and advanced multiple exploration targets in North Queensland and Canada. The company paid its 26th consecutive dividend in April, with $399 million paid in cash.

What did Evolution Mining management say?

Managing Director and Chief Executive Officer Lawrie Conway said:

Evolution continues to generate significant cash flows from consistent operational delivery and disciplined capital allocation. We have rapidly deleveraged by more than 31% in just over two years, reaching a net cash position by the end of March. There is further cash flow upside in the June quarter as we remain on track to deliver on guidance. Our financial position is outstanding with $1,371 million in cash and no debt repayments due until FY29.

What’s next for Evolution Mining?

Looking ahead, Evolution expects to further improve its net cash position in the June quarter, assuming current spot prices hold. The ramp up of new projects and continued operational improvements should support production growth and efficiency gains.

The board-approved organic growth initiatives at key operations are on schedule and budget, while ongoing exploration across the group is targeting further resource upside. Management says Evolution remains committed to disciplined capital allocation and steady returns to shareholders.

Evolution Mining share price snapshot

Over the past 12 months, Evolution Mining shares have risen 61%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Evolution Mining delivers record cash flow and moves to net cash appeared first on The Motley Fool Australia.

More reading

• Virgin Australia’s FY26 update: Hedging cushions rising fuel costs
• National Storage REIT: Scheme meetings confirm buyout pathway
• Telix Pharmaceuticals upsizes convertible bonds to US$600 million
• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company successfully priced and increased its US$600 million convertible bond offering, up from US$550 million due to strong global investor demand.

What did Telix Pharmaceuticals report?

• US$600 million of 1.50% convertible bonds due 2031, upsized from US$550 million
• Initial conversion price set at US$13.85 (~A$19.55) per ordinary share, a 37.5% premium to reference price
• Interest payable quarterly, beginning 22 July 2026
• Concurrent repurchase of approximately A$637 million of existing A$650 million convertible bonds due 2029
• Settlement of the new issuance and repurchase expected on 22 April 2026

What else do investors need to know?

The offering attracted strong support from both existing and new eligible investors worldwide, reinforcing Telix’s reputation in the global capital markets. The convertible bonds will be convertible into fully paid ordinary shares, providing potential upside for bondholders if Telix’s share price performs well over the next five years.

As part of its refinancing, Telix is also repurchasing and cancelling over 85% of its outstanding 2029 convertible bonds. The company intends to redeem the remaining bonds, further streamlining its capital structure and reducing refinancing risk.

What did Telix Pharmaceuticals management say?

Managing Director and Group CEO Dr. Christian Behrenbruch, said:

The successful completion of the convertible bonds refinance is in line with our capital management strategy and provides financial flexibility for Telix. We are pleased with the support we have received from both existing and new investors as part of the concurrent repurchase and new issue of convertible bonds.

What’s next for Telix Pharmaceuticals?

Looking ahead, Telix expects the completion of the bond issue and concurrent repurchase to enhance its capital management. These actions offer additional financial flexibility as the company pursues development and commercialisation of its radiopharmaceutical portfolio across multiple international markets.

Telix plans to continue investing in its late-stage clinical programmes and expansion, using the strengthened balance sheet to address unmet needs in oncology and rare diseases.

Telix Pharmaceuticals share price snapshot

Over the past 12 months, Telix shares have declined 41%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Telix Pharmaceuticals upsizes convertible bonds to US$600 million appeared first on The Motley Fool Australia.

More reading

• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances
• 5 things to watch on the ASX 200 on Wednesday
• Qantas Airways flags higher fuel costs and capacity changes in FY26 update
• Cleanaway Waste Management trims FY26 outlook on fuel challenges

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.